Full history for every metric is available with a Kvantra account
Inotiv, Inc. (NOTV)
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 60 | 90 | 548 | 572 | 491 | 513 | 507 |
| Operating profit | $m | -31 | -45 | |||||
| Net profit | $m | -5 | 11 | -337 | -105 | -108 | -69 | -87 |
| EPS reported | $ | -2.11 | -2.53 | |||||
| Operating cashflow per share | $ | -0.32 | 0.01 | |||||
| Capex per share | $ | 0.51 | 0.40 | |||||
| FCF per share | $ | -0.83 | -0.39 | |||||
| Free cash flow | $m | -27 | -14 | |||||
| Net debt | $m | 428 | 466 | |||||
| Book value equity | $m | 136 | 77 | |||||
| Book value per share | $ | 4.19 | 2.22 | |||||
| Number of shares | m | 32.45 | 34.65 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 0.35 | 0.04 | |||||
| P/S LTM | x | 0.09 | 0.01 | |||||
| P/FCF LTM | x | -1.74 | -0.20 | |||||
| EV/EBITDA LTM | x | 21.37 | 46.00 | |||||
| EV/Sales LTM | x | 1.03 | 0.92 | |||||
| Earnings Yield LTM | % | -145.84% | -3141.2% | |||||
| FCF Yield | % | -57.53% | -488.31% | |||||
| Quality | ||||||||
| ROE | % | -50.45% | -74.67% | |||||
| ROIC | % | -3.85% | -6.25% | |||||
| Operating margin | % | -6.02% | -8.87% | |||||
| Gross margin | % | 12.68% | 14.70% | |||||
| FCF/Sales | % | -5.28% | -2.68% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +4.54% | +5.61% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | -0.05 | -0.03 | |||||
| Net Debt/EBITDA | x | 19.47 | 46.34 | |||||
| EBIT/Net interest | x | -0.55 | -0.79 | |||||
| Net debt/market cap | % | 908.98% | 16726.8% | |||||
| Net debt/Equity | x | 3.14 | 6.05 | |||||
| Gross debt/equity | x | 3.70 | 6.33 | |||||
Company overview
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company’s BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Inotiv, Inc. (NOTV)
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company’s BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free